BRANSON, Mo. - TelAve -- Metavalis, a biotechnology innovator developing a proprietary Stealth Lipid Nanoparticle (LNP) platform, is proud to announce the launch of its "Science & Shield" humanitarian initiative. To mark this milestone, the company has partnered with community organizers to host a massive winter aid event in Branson.

While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company's leadership maintains that advanced science must be paired with immediate community care.

"Our stealth LNP technology is designed to go where other treatments can't, solving the hardest problems in medicine," said Jordan Bekemeier, Founder and CEO of Metavalis. "But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling."

More on TelAve News

• One-Click Pro Audio for Streamers: "VoiceSterize" Automates Noise Reduction & Mastering on Mac
• Sole Publishing Announces Essential Parenting Book for Families Navigating the Teen Years
• From Factory Floor to Community Heart: The Rebel Spirit of Wisconsin's Wet Wipe Innovators
• UK Financial Ltd Lists MayaFund (MFUND) ERC-20 Token on CATEX Exchange Ahead of Planned ERC-3643 Upgrade
• Denver Apartment Finders Launches Revamped Denver Tech Center Apartment Location Page

Event Details:

• Date: Saturday, February 7, 2026
• Time: 12:00 PM – 3:00 PM CST
• Location: 993 Branson Hills Parkway, Branson, MO (Parking lot)

A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:

• The Davis Family will be distributing a massive supply of winter coats, hats, and heavy weather gear to protect against the cold.
• Metavalis will be distributing "Shield Kits" care packages containing non perishable food, first aid supplies (band aids, sanitizers), and hygiene essentials.

About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The "Science & Shield" program represents the company's commitment to protecting human life at every level from the cellular to the community.

For more information, visit the Metavalis website.